Amgen Inc.
Inhibitors of KRAS G12C and methods of using the same
Last updated:
Abstract:
Provided herein are methods of using KRAS G12C inhibitors. These methods of using the inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Status:
Grant
Type:
Utility
Filling date:
12 Mar 2020
Issue date:
19 Apr 2022